Browse > Article

Difference in Protein Markers According to the Survival of Sepsis Patients using Protein Chips  

Park, Myoung Ok (Department of Internal Medicine, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Lee, Heui Young (Department of Internal Medicine, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Son, Hee Jung (Department of Anesthesia, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Sung, Ji Hyun (Department of Molecular and Cellular Biochemistry, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Lee, Seung Joon (Department of Internal Medicine, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Lee, Sung Joon (Department of Internal Medicine, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Ha, Kwon Soo (Department of Molecular and Cellular Biochemistry, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Kim, Woo Jin (Department of Internal Medicine, College of Medicine, Kangwon National University and the Clinical Research Institute of Kangwon National University Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.61, no.1, 2006 , pp. 41-45 More about this Journal
Abstract
Background; Several clinical scoring systems are currently being used to predict the outcome of sepsis, but they all have certain limitations. Therefore, we sought to identify the proteomic biomarkers, with wsing proteomic tools, that differed according to the outcome of sepsis patients. Methods; Upon admission to the ICU, blood samples were obtained from the 16 patients with sepsis who were enrolled in this study. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI -TOF MS) was used to identify the markers that could predict the outcome of sepsis. Results; We found six peaks, by using cation and anion chips, that statistically differed between those patients who died and those who survived. Conclusion; The biomarkers we found by using proteomic tools may help predict the prognosis and also plan the treatment of sepsis.
Keywords
Sepsis; Treatment outcome; Proteomics;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Zhu XD, Zhang WH, Li CL, Xu Y, Liang WJ, Tien P. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology. World J Gastroenterol 2004;10:2327-9   DOI
2 Ahn WS, Park SP, Bae SM, Lee JM, Namkoong SE, Nam GH, et al. Identification of hemoglobin-$\alpha$ and –$\beta$ subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci 2005;96:197-201   DOI   ScienceOn
3 Ilyin SE, Belkowski SM, Plata-Salaman CR. Biomarker discovery and validation: technologies and integrative approaches. Trends biotechnol 2004;22: 411-6   DOI   ScienceOn
4 Rodland KD. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin Biochem 2004;37:579-83   DOI   ScienceOn
5 Annane D, Bellisant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78   DOI   ScienceOn
6 Lemeshow S, Teres D, Avrunin JS, Gage RW. Refining intensive care unit outcome prediction by using changing probabilities of mortality. Crit Care Med 1988;16:470-7   DOI   ScienceOn
7 Papadopoulos MC, Abel PM, Agranoff D, Stich A, Tarelli E, Bell BA, et al. A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 2004363:1358-63   DOI   ScienceOn
8 Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin- guided treatment on antibiotic use and outcome in lower respiratory tract infections: clusterrandomised, single-blinded intervention trial. Lancet 2004;363:600-7   DOI   ScienceOn
9 de Rooji SE, Abu-Hanna A, Levi M, de Jonge E. Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care 2005;9:R307-14   DOI
10 Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50   DOI
11 Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29   DOI   ScienceOn
12 le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984;12:975-7   DOI   ScienceOn
13 Colonna M, Facchetti F. TREM-1: A new player in acute inflammatory responses. JInfect Dis 2003;187: S397-401   DOI
14 Polderman KH, Thijs LG, Girbes AR. Interobserver variability in the use of APACHE II score. Lancet 1999;353:380
15 Livingston BM, MacKirdy FN, Howie JC, Jones R, Norrie JD. Assessment of the performance of five intensive care scoring models within a large Scottish databases. Crit Care Med 2000;28:1820-7   DOI   ScienceOn
16 Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A Gentina T, et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006;34:532-7   DOI   ScienceOn
17 Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7   DOI   ScienceOn
18 Knaus WA, Wagner DP, Draper EA, Zimmerman JE, BergnerM, Bastos PG, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36   DOI
19 Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illnessand cost effectiveness of therapy. Pharmacoeconomics 2004;22:793-813   DOI   ScienceOn
20 Morales IJ, Peters SG, Afessa B. Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit. Crit Care Med 2003;31:858-63   DOI   ScienceOn
21 Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-8   DOI   ScienceOn
22 Rosenberg AL, Hofer TP, Strachan C, Watts CM, Hayward RA. Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures. Ann Intern Med 2003138: 882-90   DOI   ScienceOn